Noticias

Organizing Pneumonia in Hospitalized COVID-19 Patients: Risk Factors and Long-term Outcomes

mayo 24, 2024

Some patients develop post-COVID organizing pneumonia (OP), which is responsiveto treatment with corticosteroids.

Efficacy of Mepolizumab in Patients With COPD With or Without Chronic Bronchitis

mayo 20, 2024

The efficacy and safety of mepolizumab in patients with COPD has been investigated in two placebo-controlled Phase 3 trials, METREX and METREO, and theongoing MATINEE trial.

TRIPLE THERAPY AND CLINICAL CONTROL IN B+ COPD PATIENTS: A PRAGMATIC, PROSPECTIVE, RANDOMIZED TRIAL

mayo 6, 2024

Treatment with LABA/LAMA is recommended in GOLD B patients. We hypothesized that triple therapy (LABA/LAMA/ICS) will be superior to LABA/LAMA in achieving and maintaining clinical control

COPD in the 21st Century

abril 25, 2024

COPD in the 21st Century: Alvar Agustì and Rosa Faner are part of this book, being authors of chapter 4. Scientists and clinicians across many countries have made great efforts to understand this important disease, and these have yielded positive results.

Lung Tissue Multi-Layer Network Analysis Uncovers the Molecular Heterogeneity of COPD

abril 18, 2024

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition. We hypothesized that the unbiased integration of different COPD lung omics using a novel multi-layer approach may unravel mechanisms associated with clinical characteristics.

Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease

abril 15, 2024

Insight into the impact of doxycycline in therapeutic trials for COPD, emphasizing the need for careful microbiological monitoring in future interventional trials in patients with COPD

Phenotypic differences of persistent airflow obstruction in young vs old subjects in the general population

abril 11, 2024

In the general population Persistent Airflow Obstruction (PAO) was largely mild but there are significant phenotypic differences between young and old individuals with PAO

Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration

abril 5, 2024

Uncover the prevalence, characteristics, and comorbidities of asthma with airflow obstruction (AFO) in adults over 50. Learn how AFO compares to asthma-only and COPD-only in this comprehensive study.

COPD: systemic proteomic profiles in frequent and infrequent exacerbators

abril 1, 2024

Some patients with COPD suffer frequent exacerbations (FE). We hypothesised that their systemic proteomic profile would be different from that of non-frequent exacerbators (NFE).

Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness

marzo 11, 2024

The prevalence and diagnostic utility of bronchodilator responsiveness (BDR) in a real-life setting is unclear. Objective: To explore this uncertainty

Noticias

Organizing Pneumonia in Hospitalized COVID-19 Patients: Risk Factors and Long-term Outcomes

Efficacy of Mepolizumab in Patients With COPD With or Without Chronic Bronchitis

TRIPLE THERAPY AND CLINICAL CONTROL IN B+ COPD PATIENTS: A PRAGMATIC, PROSPECTIVE, RANDOMIZED TRIAL

COPD in the 21st Century

Lung Tissue Multi-Layer Network Analysis Uncovers the Molecular Heterogeneity of COPD

Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease

Phenotypic differences of persistent airflow obstruction in young vs old subjects in the general population

Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration

COPD: systemic proteomic profiles in frequent and infrequent exacerbators

Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de
Nuestras Publicaciones

Noticias

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de Nuestras Publicaciones

Entérate de
Nuestras Publicaciones